Get started
Moderna, Inc.Moderna, Inc.Moderna, Inc.

Moderna, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsETFs

1MRNA chart


Full chart

1MRNA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.46 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−6.380 EUR
Net income (FY)
‪−3.44 B‬ EUR
Revenue (FY)
‪3.13 B‬ EUR
Shares float
‪343.55 M‬
Beta (1Y)
1.19

Employees


Employees (FY)
‪5.8 K‬
Change (1Y)
+200 +3.57%
Revenue / Employee (1Y)
‪538.95 K‬ EUR
Net income / Employee (1Y)
‪−593.08 K‬ EUR

About Moderna, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Stéphane Bancel
Website
modernatx.com
Headquarters
Cambridge
Founded
2010
ISIN
US60770K1079
FIGI
BBG01C4Y0B99
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Check out other big names from the same industry as 1MRNA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1MRNA news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs with 1MRNA exposure


VTI
Vanguard Total Stock Market ETF
Weight
0.01%
Market value
‪264.29 M‬
USD
VOO
Vanguard S&P 500 ETF
Weight
0.01%
Market value
‪204.83 M‬
USD
VB
Vanguard Small-Cap ETF
Weight
0.13%
Market value
‪203.97 M‬
USD
RSP
Invesco S&P 500 Equal Weight ETF
Weight
0.23%
Market value
‪170.25 M‬
USD
VBR
Vanguard Small Cap Value ETF
Weight
0.22%
Market value
‪131.37 M‬
USD
XBI
SPDR S&P BIOTECH ETF
Weight
2.07%
Market value
‪127.14 M‬
USD
IVV
iShares Core S&P 500 ETF
Weight
0.02%
Market value
‪120.50 M‬
USD
SPY
SPDR S&P 500 ETF Trust
Weight
0.02%
Market value
‪114.35 M‬
USD
SPY
SPDR S&P 500 ETF
Weight
0.02%
Market value
‪114.35 M‬
USD
XLV
Health Care Select Sector SPDR Fund
Weight
0.19%
Market value
‪67.04 M‬
USD
IBB
iShares Biotechnology ETF
Weight
0.93%
Market value
‪57.61 M‬
USD

Explore more ETFs 

Sparks


Curated watchlists where 1MRNA is featured.

See all sparks 

Frequently Asked Questions


The current price of 1MRNA is 23.830 EUR — it has increased by 2.08% in the past 24 hours. Watch Moderna, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange Moderna, Inc. stocks are traded under the ticker 1MRNA.
1MRNA stock has risen by 11.67% compared to the previous week, the month change is a 14.46% rise, over the last year Moderna, Inc. has showed a −58.56% decrease.
We've gathered analysts' opinions on Moderna, Inc. future price: according to them, 1MRNA price has a max estimate of 170.60 EUR and a min estimate of 12.92 EUR. Watch 1MRNA chart and read a more detailed Moderna, Inc. stock forecast: see what analysts think of Moderna, Inc. and suggest that you do with its stocks.
1MRNA reached its all-time high on Dec 14, 2022 with the price of 203.000 EUR, and its all-time low was 19.900 EUR and was reached on Sep 15, 2025. View more price dynamics on 1MRNA chart.
See other stocks reaching their highest and lowest prices.
1MRNA stock is 5.27% volatile and has beta coefficient of 1.19. Track Moderna, Inc. stock price on the chart and check out the list of the most volatile stocks — is Moderna, Inc. there?
Today Moderna, Inc. has the market capitalization of ‪9.46 B‬, it has decreased by −0.16% over the last week.
Yes, you can track Moderna, Inc. financials in yearly and quarterly reports right on TradingView.
Moderna, Inc. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
1MRNA earnings for the last quarter are −1.81 EUR per share, whereas the estimation was −2.54 EUR resulting in a 28.75% surprise. The estimated earnings for the next quarter are −1.75 EUR per share. See more details about Moderna, Inc. earnings.
Moderna, Inc. revenue for the last quarter amounts to ‪120.54 M‬ EUR, despite the estimated figure of ‪94.06 M‬ EUR. In the next quarter, revenue is expected to reach ‪772.24 M‬ EUR.
1MRNA net income for the last quarter is ‪−700.35 M‬ EUR, while the quarter before that showed ‪−897.54 M‬ EUR of net income which accounts for 21.97% change. Track more Moderna, Inc. financial stats to get the full picture.
No, 1MRNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 4, 2025, the company has ‪5.8 K‬ employees. See our rating of the largest employees — is Moderna, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Moderna, Inc. EBITDA is ‪−2.60 B‬ EUR, and current EBITDA margin is −116.07%. See more stats in Moderna, Inc. financial statements.
Like other stocks, 1MRNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Moderna, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Moderna, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Moderna, Inc. stock shows the sell signal. See more of Moderna, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.